Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1.
<h4>Background</h4>Statins have previously been shown to reduce the in vitro infection of human immunodeficiency virus type 1 (HIV-1) through modulation of Rho GTPase activity and lipid raft formation at the cell surface, as well as by disrupting LFA-1 incorporation into viral particles....
Main Authors: | Alexey A Nabatov, Georgios Pollakis, Thomas Linnemann, William A Paxton, Michel P de Baar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-05-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0000470 |
Similar Items
-
Effect of CCR5 activation by RANTES on adipocyte differentiation
by: Shao-Yun Wu, et al.
Published: (2019) -
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
by: Rebecca Nedellec, et al.
Published: (2011-01-01) -
The Influence of RANTES and Its Receptor (CCR5) on Pancreatic Insulin Secretion
by: Chien Hui Hung, et al.
Published: (2019) -
Expression level of Eotaxin, MCP-1, RANTES, CCR5, CCR3 and CCR2 of Taiwanese and Aboriginal Taiwanese
by: Keniji Liu, et al.
Published: (2002) -
RANTES and T lymphocytes
by: Turner, Lynn
Published: (1996)